Takeda Shinhiro, Ishizaka Akitoshi, Fujino Yuji, Fukuoka Toshio, Nagano Osamu, Yamada Yoshitsugu, Takezawa Jun
Department of Anesthesiology and Intensive Care, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan.
Pulm Pharmacol Ther. 2005;18(2):115-9. doi: 10.1016/j.pupt.2004.11.001.
Because of high mortality and morbidity, acute respiratory distress syndrome (ARDS) continues to be one of the clinical challenges for intensivists. The diagnostic criteria for ARDS published by the American-European consensus conference were over simplified and made it possible to conduct large-scale randomized controlled trails (RCTs). Thus, many RCTs have been conducted in attempts to evaluate new treatment modalities, but many have reported negative results, in part because this definition was too broad to be used as diagnostic criteria. Pulmonary ARDS and extrapulmonary ARDS differ in terms of their morbidity and mortality with the presence of organ failure being an important risk factor for mortality in ARDS patients. The Classification of ARDS into several subgroups, which take the underlying disease into account, might limit the number of patients enrolled in an RCT. Where as this subgroup classification would enable selection of a homogeneous population of ARDS patients and may be a key to conducting more focused RCTs and, therefore, having more reliable results.
由于高死亡率和高发病率,急性呼吸窘迫综合征(ARDS)仍然是重症监护医生面临的临床挑战之一。美国-欧洲共识会议发布的ARDS诊断标准过于简化,使得大规模随机对照试验(RCT)得以开展。因此,许多RCT被进行以评估新的治疗方式,但许多试验报告了阴性结果,部分原因是该定义过于宽泛,无法用作诊断标准。肺型ARDS和肺外型ARDS在发病率和死亡率方面存在差异,器官功能衰竭的存在是ARDS患者死亡的重要危险因素。将ARDS分为几个亚组,同时考虑潜在疾病,可能会限制纳入RCT的患者数量。然而,这种亚组分类将有助于选择同质化的ARDS患者群体,可能是开展更具针对性的RCT并因此获得更可靠结果的关键。